Sivelestat, a selective ELANE and PRTN3 inhibitor [33] was shown to improve the mortality rates of patients with sepsis associated with acute respiratory distress syndrome and disseminated intravascular coagulation [34]. This evidence concerns the gene PRTN3 and Disseminated intravascular coagulation.